SCHEMBL30889010

SCHEMBL30889010

Cc1nc2cc(F)c(Br)cc2n1C(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 9/20 0.36
CCND1 P24385 8/20 0.36
CCND3 P30281 7/20 0.36
CDK6 Q00534 7/20 0.36
CSNK1E P49674 1/20 0.35
CLK1 P49759 1/20 0.35
CLK2 P49760 1/20 0.35
CLK3 P49761 1/20 0.35
GSK3B P49841 1/20 0.35
CDK5 Q00535 1/20 0.35
DYRK1A Q13627 1/20 0.35
CDK5R1 Q15078 1/20 0.35
DYRK2 Q92630 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
DYRK4 Q9NR20 1/20 0.35
DYRK1B Q9Y463 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
HDAC1 Q13547 1/20 0.34
EGFR P00533 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21522918 1.00 CDK4 (0.36) CDK4CCND1CCND3CDK6CSNK1E
SCHEMBL15826117 0.79 ADORA3 (0.36) CYP11B1CYP11B2ALOX15HTT
SCHEMBL29827557 0.73 FABP4 (0.48) CDK4CCND1CDK6CSNK1ECLK1
SCHEMBL8130706 0.73 CYP11B1 (0.45) CSNK1ECLK1CLK2CLK3GSK3B
SCHEMBL12853410 0.73 FABP4 (0.48) CDK4CCND1CDK6CSNK1ECLK1
SCHEMBL9081176 0.73 CCNT1 (0.49) CDK4CCND1CCND3CDK6CSNK1E
SCHEMBL15742079 0.72 EGFR (0.42) EGFR
SCHEMBL16806047 0.71 KDM4E (0.51) CYP11B1CYP11B2HDAC1ALOX15HTT
SCHEMBL2490112 0.71 PLK4 (0.40) CDK4CDK6HDAC1CDK1CCNB1
SCHEMBL30309559 0.71 PLK4 (0.40) CDK4CDK6HDAC1CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129104-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2025-04-24 US disclosed
CN-118286225-A 2-Amino-pyridine or 2-amino-pyrimidine derivatives as cyclin dependent kinase inhibitors 辉瑞公司 2024-07-05 CN disclosed
CN-112313219-B 2-Amino-pyridine or 2-amino-pyrimidine derivatives as cyclin dependent kinase inhibitors 辉瑞公司 2024-04-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129104-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 CDK4 316/4885CCND1 463/4885CCND3 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.